nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclizine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0839	0.127	CbGbCtD
Cyclizine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0768	0.116	CbGbCtD
Cyclizine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0714	0.108	CbGbCtD
Cyclizine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0607	0.0916	CbGbCtD
Cyclizine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0607	0.0916	CbGbCtD
Cyclizine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.056	0.0845	CbGbCtD
Cyclizine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0541	0.0816	CbGbCtD
Cyclizine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0495	0.0747	CbGbCtD
Cyclizine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.046	0.0694	CbGbCtD
Cyclizine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0441	0.0665	CbGbCtD
Cyclizine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0311	0.0469	CbGbCtD
Cyclizine—CYP2C9—Losartan—type 2 diabetes mellitus	0.0284	0.0429	CbGbCtD
Cyclizine—Bepridil—KCNQ1—type 2 diabetes mellitus	0.000929	0.133	CrCbGaD
Cyclizine—Erythema—Glyburide—type 2 diabetes mellitus	0.000564	0.00239	CcSEcCtD
Cyclizine—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.000562	0.00238	CcSEcCtD
Cyclizine—Headache—Linagliptin—type 2 diabetes mellitus	0.000559	0.00237	CcSEcCtD
Cyclizine—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.000558	0.00236	CcSEcCtD
Cyclizine—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.000557	0.00236	CcSEcCtD
Cyclizine—Hepatobiliary disease—Orlistat—type 2 diabetes mellitus	0.000556	0.00236	CcSEcCtD
Cyclizine—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.000556	0.00236	CcSEcCtD
Cyclizine—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000552	0.00234	CcSEcCtD
Cyclizine—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.000546	0.00231	CcSEcCtD
Cyclizine—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.000545	0.00231	CcSEcCtD
Cyclizine—Eye disorder—Gliclazide—type 2 diabetes mellitus	0.000544	0.0023	CcSEcCtD
Cyclizine—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.000543	0.0023	CcSEcCtD
Cyclizine—Drowsiness—Metformin—type 2 diabetes mellitus	0.000542	0.0023	CcSEcCtD
Cyclizine—Insomnia—Glipizide—type 2 diabetes mellitus	0.000541	0.00229	CcSEcCtD
Cyclizine—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.00054	0.00229	CcSEcCtD
Cyclizine—Paraesthesia—Glipizide—type 2 diabetes mellitus	0.000537	0.00227	CcSEcCtD
Cyclizine—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.000535	0.00226	CcSEcCtD
Cyclizine—Hepatitis—Valsartan—type 2 diabetes mellitus	0.000535	0.00226	CcSEcCtD
Cyclizine—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.000533	0.00226	CcSEcCtD
Cyclizine—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000533	0.00225	CcSEcCtD
Cyclizine—Somnolence—Glipizide—type 2 diabetes mellitus	0.000532	0.00225	CcSEcCtD
Cyclizine—Vision blurred—Glyburide—type 2 diabetes mellitus	0.000532	0.00225	CcSEcCtD
Cyclizine—Tremor—Glyburide—type 2 diabetes mellitus	0.000528	0.00224	CcSEcCtD
Cyclizine—Hepatitis—Orlistat—type 2 diabetes mellitus	0.000528	0.00224	CcSEcCtD
Cyclizine—Connective tissue disorder—Valsartan—type 2 diabetes mellitus	0.000525	0.00222	CcSEcCtD
Cyclizine—Chills—Gliclazide—type 2 diabetes mellitus	0.000522	0.00221	CcSEcCtD
Cyclizine—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000522	0.00221	CcSEcCtD
Cyclizine—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000518	0.00219	CcSEcCtD
Cyclizine—Angioedema—Glyburide—type 2 diabetes mellitus	0.000515	0.00218	CcSEcCtD
Cyclizine—Hepatobiliary disease—Metformin—type 2 diabetes mellitus	0.000513	0.00217	CcSEcCtD
Cyclizine—Constipation—Glipizide—type 2 diabetes mellitus	0.000511	0.00217	CcSEcCtD
Cyclizine—Pain—Glipizide—type 2 diabetes mellitus	0.000511	0.00217	CcSEcCtD
Cyclizine—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000511	0.00217	CcSEcCtD
Cyclizine—Flunarizine—CALM1—type 2 diabetes mellitus	0.00051	0.073	CrCbGaD
Cyclizine—Mental disorder—Gliclazide—type 2 diabetes mellitus	0.00051	0.00216	CcSEcCtD
Cyclizine—Erythema—Gliclazide—type 2 diabetes mellitus	0.000506	0.00214	CcSEcCtD
Cyclizine—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000505	0.00214	CcSEcCtD
Cyclizine—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000503	0.00213	CcSEcCtD
Cyclizine—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.000501	0.00212	CcSEcCtD
Cyclizine—Tension—Gliclazide—type 2 diabetes mellitus	0.000497	0.0021	CcSEcCtD
Cyclizine—Somnolence—Glimepiride—type 2 diabetes mellitus	0.000496	0.0021	CcSEcCtD
Cyclizine—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000495	0.00209	CcSEcCtD
Cyclizine—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000494	0.00209	CcSEcCtD
Cyclizine—Nervousness—Gliclazide—type 2 diabetes mellitus	0.000492	0.00208	CcSEcCtD
Cyclizine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000491	0.00208	CcSEcCtD
Cyclizine—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.00049	0.00208	CcSEcCtD
Cyclizine—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000489	0.00207	CcSEcCtD
Cyclizine—Convulsion—Glyburide—type 2 diabetes mellitus	0.000489	0.00207	CcSEcCtD
Cyclizine—Hepatitis—Metformin—type 2 diabetes mellitus	0.000487	0.00206	CcSEcCtD
Cyclizine—Hepatobiliary disease—Irbesartan—type 2 diabetes mellitus	0.000484	0.00205	CcSEcCtD
Cyclizine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000483	0.00205	CcSEcCtD
Cyclizine—Connective tissue disorder—Metformin—type 2 diabetes mellitus	0.000478	0.00202	CcSEcCtD
Cyclizine—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000478	0.00202	CcSEcCtD
Cyclizine—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000476	0.00201	CcSEcCtD
Cyclizine—Pain—Sitagliptin—type 2 diabetes mellitus	0.000476	0.00201	CcSEcCtD
Cyclizine—Urticaria—Glipizide—type 2 diabetes mellitus	0.000475	0.00201	CcSEcCtD
Cyclizine—Tremor—Gliclazide—type 2 diabetes mellitus	0.000475	0.00201	CcSEcCtD
Cyclizine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000471	0.00199	CcSEcCtD
Cyclizine—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000468	0.00198	CcSEcCtD
Cyclizine—Agitation—Gliclazide—type 2 diabetes mellitus	0.000465	0.00197	CcSEcCtD
Cyclizine—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000463	0.00196	CcSEcCtD
Cyclizine—Mental disorder—Orlistat—type 2 diabetes mellitus	0.000463	0.00196	CcSEcCtD
Cyclizine—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.000459	0.00194	CcSEcCtD
Cyclizine—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.000456	0.00193	CcSEcCtD
Cyclizine—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000455	0.00193	CcSEcCtD
Cyclizine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000455	0.00193	CcSEcCtD
Cyclizine—Eye disorder—Metformin—type 2 diabetes mellitus	0.000455	0.00193	CcSEcCtD
Cyclizine—Headache—Repaglinide—type 2 diabetes mellitus	0.000453	0.00192	CcSEcCtD
Cyclizine—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000452	0.00191	CcSEcCtD
Cyclizine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000452	0.00191	CcSEcCtD
Cyclizine—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000451	0.00191	CcSEcCtD
Cyclizine—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000451	0.00191	CcSEcCtD
Cyclizine—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000449	0.0019	CcSEcCtD
Cyclizine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000448	0.0019	CcSEcCtD
Cyclizine—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000447	0.00189	CcSEcCtD
Cyclizine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000443	0.00188	CcSEcCtD
Cyclizine—Bepridil—CALM1—type 2 diabetes mellitus	0.000443	0.0634	CrCbGaD
Cyclizine—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000442	0.00187	CcSEcCtD
Cyclizine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000442	0.00187	CcSEcCtD
Cyclizine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000441	0.00187	CcSEcCtD
Cyclizine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000439	0.00186	CcSEcCtD
Cyclizine—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000439	0.00186	CcSEcCtD
Cyclizine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000437	0.00185	CcSEcCtD
Cyclizine—Chills—Metformin—type 2 diabetes mellitus	0.000437	0.00185	CcSEcCtD
Cyclizine—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000433	0.00183	CcSEcCtD
Cyclizine—Hepatitis—Losartan—type 2 diabetes mellitus	0.000432	0.00183	CcSEcCtD
Cyclizine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000431	0.00182	CcSEcCtD
Cyclizine—Hypotension—Glyburide—type 2 diabetes mellitus	0.00043	0.00182	CcSEcCtD
Cyclizine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000429	0.00182	CcSEcCtD
Cyclizine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000428	0.00181	CcSEcCtD
Cyclizine—Angioedema—Valsartan—type 2 diabetes mellitus	0.000425	0.0018	CcSEcCtD
Cyclizine—Erythema—Metformin—type 2 diabetes mellitus	0.000424	0.00179	CcSEcCtD
Cyclizine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000423	0.00179	CcSEcCtD
Cyclizine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000422	0.00179	CcSEcCtD
Cyclizine—Angioedema—Orlistat—type 2 diabetes mellitus	0.00042	0.00178	CcSEcCtD
Cyclizine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000413	0.00175	CcSEcCtD
Cyclizine—Chills—Irbesartan—type 2 diabetes mellitus	0.000412	0.00174	CcSEcCtD
Cyclizine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000411	0.00174	CcSEcCtD
Cyclizine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000411	0.00174	CcSEcCtD
Cyclizine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00041	0.00174	CcSEcCtD
Cyclizine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000407	0.00172	CcSEcCtD
Cyclizine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000405	0.00172	CcSEcCtD
Cyclizine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000403	0.00171	CcSEcCtD
Cyclizine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000401	0.0017	CcSEcCtD
Cyclizine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.0004	0.0017	CcSEcCtD
Cyclizine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.0004	0.00169	CcSEcCtD
Cyclizine—Erythema—Irbesartan—type 2 diabetes mellitus	0.0004	0.00169	CcSEcCtD
Cyclizine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000399	0.00169	CcSEcCtD
Cyclizine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000399	0.00169	CcSEcCtD
Cyclizine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000398	0.00169	CcSEcCtD
Cyclizine—Tremor—Metformin—type 2 diabetes mellitus	0.000397	0.00168	CcSEcCtD
Cyclizine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000396	0.00167	CcSEcCtD
Cyclizine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000395	0.00167	CcSEcCtD
Cyclizine—Tension—Irbesartan—type 2 diabetes mellitus	0.000392	0.00166	CcSEcCtD
Cyclizine—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000391	0.00165	CcSEcCtD
Cyclizine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000388	0.00164	CcSEcCtD
Cyclizine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000386	0.00164	CcSEcCtD
Cyclizine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000385	0.00163	CcSEcCtD
Cyclizine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000384	0.00163	CcSEcCtD
Cyclizine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00038	0.00161	CcSEcCtD
Cyclizine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000379	0.0016	CcSEcCtD
Cyclizine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000377	0.0016	CcSEcCtD
Cyclizine—Erythema—Losartan—type 2 diabetes mellitus	0.000376	0.00159	CcSEcCtD
Cyclizine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000375	0.00159	CcSEcCtD
Cyclizine—Headache—Glipizide—type 2 diabetes mellitus	0.000375	0.00159	CcSEcCtD
Cyclizine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000375	0.00159	CcSEcCtD
Cyclizine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000374	0.00158	CcSEcCtD
Cyclizine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000372	0.00158	CcSEcCtD
Cyclizine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000371	0.00157	CcSEcCtD
Cyclizine—Reboxetine—HTR2C—type 2 diabetes mellitus	0.000371	0.0531	CrCbGaD
Cyclizine—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000371	0.00157	CcSEcCtD
Cyclizine—Tension—Losartan—type 2 diabetes mellitus	0.000369	0.00156	CcSEcCtD
Cyclizine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000369	0.00156	CcSEcCtD
Cyclizine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000369	0.00156	CcSEcCtD
Cyclizine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000368	0.00156	CcSEcCtD
Cyclizine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000368	0.00156	CcSEcCtD
Cyclizine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000367	0.00156	CcSEcCtD
Cyclizine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000367	0.00156	CcSEcCtD
Cyclizine—Hypertension—Metformin—type 2 diabetes mellitus	0.000366	0.00155	CcSEcCtD
Cyclizine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000366	0.00155	CcSEcCtD
Cyclizine—Nervousness—Losartan—type 2 diabetes mellitus	0.000366	0.00155	CcSEcCtD
Cyclizine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000365	0.00155	CcSEcCtD
Cyclizine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000364	0.00154	CcSEcCtD
Cyclizine—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000364	0.00154	CcSEcCtD
Cyclizine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000362	0.00153	CcSEcCtD
Cyclizine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000361	0.00153	CcSEcCtD
Cyclizine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000359	0.00152	CcSEcCtD
Cyclizine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000355	0.0015	CcSEcCtD
Cyclizine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000355	0.0015	CcSEcCtD
Cyclizine—Pain—Gliclazide—type 2 diabetes mellitus	0.000353	0.0015	CcSEcCtD
Cyclizine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000353	0.0015	CcSEcCtD
Cyclizine—Tremor—Losartan—type 2 diabetes mellitus	0.000353	0.00149	CcSEcCtD
Cyclizine—Headache—Glimepiride—type 2 diabetes mellitus	0.00035	0.00148	CcSEcCtD
Cyclizine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000349	0.00148	CcSEcCtD
Cyclizine—Agitation—Losartan—type 2 diabetes mellitus	0.000346	0.00146	CcSEcCtD
Cyclizine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000345	0.00146	CcSEcCtD
Cyclizine—Phenoxybenzamine—CALM1—type 2 diabetes mellitus	0.000345	0.0494	CrCbGaD
Cyclizine—Angioedema—Losartan—type 2 diabetes mellitus	0.000344	0.00146	CcSEcCtD
Cyclizine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000343	0.00145	CcSEcCtD
Cyclizine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000341	0.00144	CcSEcCtD
Cyclizine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000339	0.00144	CcSEcCtD
Cyclizine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000339	0.00144	CcSEcCtD
Cyclizine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000339	0.00144	CcSEcCtD
Cyclizine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000338	0.00143	CcSEcCtD
Cyclizine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000337	0.00143	CcSEcCtD
Cyclizine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000336	0.00142	CcSEcCtD
Cyclizine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000333	0.00141	CcSEcCtD
Cyclizine—Asthenia—Glyburide—type 2 diabetes mellitus	0.00033	0.0014	CcSEcCtD
Cyclizine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000328	0.00139	CcSEcCtD
Cyclizine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000326	0.00138	CcSEcCtD
Cyclizine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000326	0.00138	CcSEcCtD
Cyclizine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000325	0.00137	CcSEcCtD
Cyclizine—Constipation—Valsartan—type 2 diabetes mellitus	0.000325	0.00137	CcSEcCtD
Cyclizine—Hypotension—Metformin—type 2 diabetes mellitus	0.000323	0.00137	CcSEcCtD
Cyclizine—Erythema—Ramipril—type 2 diabetes mellitus	0.000323	0.00137	CcSEcCtD
Cyclizine—Pain—Orlistat—type 2 diabetes mellitus	0.000321	0.00136	CcSEcCtD
Cyclizine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00032	0.00135	CcSEcCtD
Cyclizine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000319	0.00135	CcSEcCtD
Cyclizine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000317	0.00134	CcSEcCtD
Cyclizine—Tension—Ramipril—type 2 diabetes mellitus	0.000317	0.00134	CcSEcCtD
Cyclizine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000315	0.00134	CcSEcCtD
Cyclizine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000313	0.00133	CcSEcCtD
Cyclizine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000311	0.00131	CcSEcCtD
Cyclizine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.00031	0.00131	CcSEcCtD
Cyclizine—Somnolence—Metformin—type 2 diabetes mellitus	0.000307	0.0013	CcSEcCtD
Cyclizine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000307	0.0013	CcSEcCtD
Cyclizine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000305	0.00129	CcSEcCtD
Cyclizine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000305	0.00129	CcSEcCtD
Cyclizine—Tremor—Ramipril—type 2 diabetes mellitus	0.000302	0.00128	CcSEcCtD
Cyclizine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000302	0.00128	CcSEcCtD
Cyclizine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000301	0.00128	CcSEcCtD
Cyclizine—Tachycardia—Losartan—type 2 diabetes mellitus	0.0003	0.00127	CcSEcCtD
Cyclizine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000298	0.00126	CcSEcCtD
Cyclizine—Meclizine—CYP1A2—type 2 diabetes mellitus	0.000298	0.0426	CrCbGaD
Cyclizine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000297	0.00126	CcSEcCtD
Cyclizine—Agitation—Ramipril—type 2 diabetes mellitus	0.000297	0.00126	CcSEcCtD
Cyclizine—Constipation—Metformin—type 2 diabetes mellitus	0.000296	0.00125	CcSEcCtD
Cyclizine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000295	0.00125	CcSEcCtD
Cyclizine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000293	0.00124	CcSEcCtD
Cyclizine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000292	0.00124	CcSEcCtD
Cyclizine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00029	0.00123	CcSEcCtD
Cyclizine—Headache—Glyburide—type 2 diabetes mellitus	0.000288	0.00122	CcSEcCtD
Cyclizine—Hypotension—Losartan—type 2 diabetes mellitus	0.000287	0.00121	CcSEcCtD
Cyclizine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00028	0.00118	CcSEcCtD
Cyclizine—Convulsion—Ramipril—type 2 diabetes mellitus	0.00028	0.00118	CcSEcCtD
Cyclizine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000279	0.00118	CcSEcCtD
Cyclizine—Pain—Irbesartan—type 2 diabetes mellitus	0.000279	0.00118	CcSEcCtD
Cyclizine—Insomnia—Losartan—type 2 diabetes mellitus	0.000278	0.00118	CcSEcCtD
Cyclizine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000276	0.00117	CcSEcCtD
Cyclizine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000276	0.00117	CcSEcCtD
Cyclizine—Urticaria—Metformin—type 2 diabetes mellitus	0.000275	0.00116	CcSEcCtD
Cyclizine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000273	0.00116	CcSEcCtD
Cyclizine—Somnolence—Losartan—type 2 diabetes mellitus	0.000273	0.00116	CcSEcCtD
Cyclizine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000272	0.00115	CcSEcCtD
Cyclizine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000269	0.00114	CcSEcCtD
Cyclizine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000269	0.00114	CcSEcCtD
Cyclizine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000265	0.00112	CcSEcCtD
Cyclizine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000263	0.00111	CcSEcCtD
Cyclizine—Pain—Losartan—type 2 diabetes mellitus	0.000263	0.00111	CcSEcCtD
Cyclizine—Constipation—Losartan—type 2 diabetes mellitus	0.000263	0.00111	CcSEcCtD
Cyclizine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000259	0.0011	CcSEcCtD
Cyclizine—Headache—Gliclazide—type 2 diabetes mellitus	0.000259	0.0011	CcSEcCtD
Cyclizine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000258	0.00109	CcSEcCtD
Cyclizine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000257	0.00109	CcSEcCtD
Cyclizine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000256	0.00108	CcSEcCtD
Cyclizine—Metixene—HTR2C—type 2 diabetes mellitus	0.000254	0.0364	CrCbGaD
Cyclizine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000251	0.00106	CcSEcCtD
Cyclizine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000248	0.00105	CcSEcCtD
Cyclizine—Asthenia—Metformin—type 2 diabetes mellitus	0.000248	0.00105	CcSEcCtD
Cyclizine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000246	0.00104	CcSEcCtD
Cyclizine—Pruritus—Metformin—type 2 diabetes mellitus	0.000245	0.00104	CcSEcCtD
Cyclizine—Urticaria—Losartan—type 2 diabetes mellitus	0.000244	0.00103	CcSEcCtD
Cyclizine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00024	0.00102	CcSEcCtD
Cyclizine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000238	0.00101	CcSEcCtD
Cyclizine—Headache—Valsartan—type 2 diabetes mellitus	0.000238	0.00101	CcSEcCtD
Cyclizine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000236	0.001	CcSEcCtD
Cyclizine—Headache—Orlistat—type 2 diabetes mellitus	0.000235	0.000995	CcSEcCtD
Cyclizine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000234	0.000991	CcSEcCtD
Cyclizine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000234	0.000991	CcSEcCtD
Cyclizine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000231	0.000977	CcSEcCtD
Cyclizine—Dizziness—Metformin—type 2 diabetes mellitus	0.000229	0.000968	CcSEcCtD
Cyclizine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000226	0.000958	CcSEcCtD
Cyclizine—Constipation—Ramipril—type 2 diabetes mellitus	0.000225	0.000953	CcSEcCtD
Cyclizine—Asthenia—Losartan—type 2 diabetes mellitus	0.00022	0.000933	CcSEcCtD
Cyclizine—Pruritus—Losartan—type 2 diabetes mellitus	0.000217	0.00092	CcSEcCtD
Cyclizine—Headache—Metformin—type 2 diabetes mellitus	0.000217	0.000917	CcSEcCtD
Cyclizine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000216	0.000914	CcSEcCtD
Cyclizine—Bifonazole—CYP2E1—type 2 diabetes mellitus	0.00021	0.03	CrCbGaD
Cyclizine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000209	0.000886	CcSEcCtD
Cyclizine—Headache—Irbesartan—type 2 diabetes mellitus	0.000204	0.000866	CcSEcCtD
Cyclizine—Dizziness—Losartan—type 2 diabetes mellitus	0.000203	0.00086	CcSEcCtD
Cyclizine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000194	0.000821	CcSEcCtD
Cyclizine—Cyproheptadine—HTR2C—type 2 diabetes mellitus	0.000193	0.0276	CrCbGaD
Cyclizine—Headache—Losartan—type 2 diabetes mellitus	0.000192	0.000815	CcSEcCtD
Cyclizine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000189	0.0008	CcSEcCtD
Cyclizine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000186	0.000789	CcSEcCtD
Cyclizine—Reboxetine—CYP3A4—type 2 diabetes mellitus	0.000185	0.0265	CrCbGaD
Cyclizine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000174	0.000737	CcSEcCtD
Cyclizine—Headache—Ramipril—type 2 diabetes mellitus	0.000165	0.000698	CcSEcCtD
Cyclizine—Benzphetamine—ADRA2A—type 2 diabetes mellitus	0.000163	0.0234	CrCbGaD
Cyclizine—Prochlorperazine—HTR2C—type 2 diabetes mellitus	0.000161	0.0231	CrCbGaD
Cyclizine—Flunarizine—CYP1A2—type 2 diabetes mellitus	0.00016	0.0229	CrCbGaD
Cyclizine—Mianserin—ADRA2A—type 2 diabetes mellitus	0.000159	0.0227	CrCbGaD
Cyclizine—Phenoxybenzamine—ADRA2A—type 2 diabetes mellitus	0.000156	0.0224	CrCbGaD
Cyclizine—Atomoxetine—HTR2C—type 2 diabetes mellitus	0.000149	0.0214	CrCbGaD
Cyclizine—Mianserin—HTR2C—type 2 diabetes mellitus	0.000146	0.0209	CrCbGaD
Cyclizine—Bifonazole—CYP3A4—type 2 diabetes mellitus	0.000132	0.0189	CrCbGaD
Cyclizine—Modafinil—CYP1A2—type 2 diabetes mellitus	0.000131	0.0188	CrCbGaD
Cyclizine—Cinnarizine—CYP1A2—type 2 diabetes mellitus	0.000127	0.0181	CrCbGaD
Cyclizine—Loxapine—ADRA2A—type 2 diabetes mellitus	0.000126	0.018	CrCbGaD
Cyclizine—Phenprocoumon—CYP3A4—type 2 diabetes mellitus	0.000119	0.0171	CrCbGaD
Cyclizine—Loxapine—HTR2C—type 2 diabetes mellitus	0.000116	0.0166	CrCbGaD
Cyclizine—Mianserin—CYP1A2—type 2 diabetes mellitus	0.00011	0.0158	CrCbGaD
Cyclizine—Clozapine—ADRA2A—type 2 diabetes mellitus	0.000106	0.0151	CrCbGaD
Cyclizine—Phenprocoumon—ALB—type 2 diabetes mellitus	0.000104	0.0149	CrCbGaD
Cyclizine—Clozapine—HTR2C—type 2 diabetes mellitus	9.73e-05	0.0139	CrCbGaD
Cyclizine—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	9.1e-05	0.013	CrCbGaD
Cyclizine—Orphenadrine—CYP2E1—type 2 diabetes mellitus	9.05e-05	0.013	CrCbGaD
Cyclizine—Modafinil—CYP3A4—type 2 diabetes mellitus	8.67e-05	0.0124	CrCbGaD
Cyclizine—Fentanyl—CYP3A4—type 2 diabetes mellitus	8.48e-05	0.0121	CrCbGaD
Cyclizine—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	8.06e-05	0.0115	CrCbGaD
Cyclizine—Clozapine—CYP2E1—type 2 diabetes mellitus	7.72e-05	0.0111	CrCbGaD
Cyclizine—Benzphetamine—CYP3A4—type 2 diabetes mellitus	7.52e-05	0.0108	CrCbGaD
Cyclizine—Atomoxetine—CYP3A4—type 2 diabetes mellitus	7.46e-05	0.0107	CrCbGaD
Cyclizine—Clozapine—CYP1A2—type 2 diabetes mellitus	7.34e-05	0.0105	CrCbGaD
Cyclizine—Mianserin—CYP3A4—type 2 diabetes mellitus	7.29e-05	0.0104	CrCbGaD
Cyclizine—Phenoxybenzamine—CYP3A4—type 2 diabetes mellitus	7.18e-05	0.0103	CrCbGaD
Cyclizine—Orphenadrine—CYP3A4—type 2 diabetes mellitus	5.7e-05	0.00816	CrCbGaD
Cyclizine—HRH1—GPCR ligand binding—GNB3—type 2 diabetes mellitus	5.48e-05	0.000581	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	5.47e-05	0.00058	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	5.43e-05	0.000576	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—AVP—type 2 diabetes mellitus	5.41e-05	0.000573	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	5.32e-05	0.000564	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	5.28e-05	0.00056	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	5.18e-05	0.00055	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—EDN1—type 2 diabetes mellitus	5.14e-05	0.000545	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	5.1e-05	0.000541	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	4.94e-05	0.000523	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	4.94e-05	0.000523	CbGpPWpGaD
Cyclizine—Clozapine—CYP3A4—type 2 diabetes mellitus	4.86e-05	0.00696	CrCbGaD
Cyclizine—CYP2C9—Metabolism—BHMT—type 2 diabetes mellitus	4.84e-05	0.000513	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	4.83e-05	0.000512	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	4.71e-05	0.000499	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GCGR—type 2 diabetes mellitus	4.69e-05	0.000497	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	4.63e-05	0.000491	CbGpPWpGaD
Cyclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	4.62e-05	0.00049	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—CCR5—type 2 diabetes mellitus	4.6e-05	0.000487	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	4.59e-05	0.000487	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—C3—type 2 diabetes mellitus	4.49e-05	0.000476	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	4.48e-05	0.000475	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	4.46e-05	0.000473	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GRK5—type 2 diabetes mellitus	4.32e-05	0.000458	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GIPR—type 2 diabetes mellitus	4.32e-05	0.000458	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	4.27e-05	0.000453	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—AGT—type 2 diabetes mellitus	4.27e-05	0.000453	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PTGDS—type 2 diabetes mellitus	4.23e-05	0.000449	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AANAT—type 2 diabetes mellitus	4.23e-05	0.000449	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	4.17e-05	0.000442	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	4.14e-05	0.000439	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	4.07e-05	0.000432	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	4.05e-05	0.000429	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	4.03e-05	0.000427	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	4.02e-05	0.000427	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CDO1—type 2 diabetes mellitus	4.01e-05	0.000425	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GPD2—type 2 diabetes mellitus	4.01e-05	0.000425	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MC4R—type 2 diabetes mellitus	3.95e-05	0.000419	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	3.95e-05	0.000418	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	3.93e-05	0.000417	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	3.92e-05	0.000416	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	3.9e-05	0.000413	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	3.88e-05	0.000412	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	3.88e-05	0.000411	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AK1—type 2 diabetes mellitus	3.83e-05	0.000406	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GIP—type 2 diabetes mellitus	3.8e-05	0.000403	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	3.78e-05	0.000401	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	3.76e-05	0.000399	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	3.66e-05	0.000388	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LEPR—type 2 diabetes mellitus	3.61e-05	0.000383	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	3.6e-05	0.000382	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	3.59e-05	0.000381	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	3.58e-05	0.00038	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	3.57e-05	0.000378	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	3.54e-05	0.000375	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC5A4—type 2 diabetes mellitus	3.53e-05	0.000374	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—MAT1A—type 2 diabetes mellitus	3.53e-05	0.000374	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	3.52e-05	0.000374	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	3.52e-05	0.000373	CbGpPWpGaD
Cyclizine—HRH1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	3.52e-05	0.000373	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	3.45e-05	0.000366	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	3.45e-05	0.000366	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	3.42e-05	0.000363	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HBA2—type 2 diabetes mellitus	3.41e-05	0.000362	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ND1—type 2 diabetes mellitus	3.41e-05	0.000362	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—G6PC—type 2 diabetes mellitus	3.41e-05	0.000362	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ENPP1—type 2 diabetes mellitus	3.41e-05	0.000362	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPP1R3C—type 2 diabetes mellitus	3.41e-05	0.000362	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TLE4—type 2 diabetes mellitus	3.36e-05	0.000356	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GCGR—type 2 diabetes mellitus	3.3e-05	0.00035	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—GCG—type 2 diabetes mellitus	3.26e-05	0.000346	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	3.23e-05	0.000343	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	3.21e-05	0.00034	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	3.18e-05	0.000337	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	3.12e-05	0.000331	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—OXCT1—type 2 diabetes mellitus	3.12e-05	0.000331	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYTB—type 2 diabetes mellitus	3.12e-05	0.000331	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	3.1e-05	0.000328	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	3.06e-05	0.000324	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SRD5A1—type 2 diabetes mellitus	3.04e-05	0.000322	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	2.91e-05	0.000308	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ACACA—type 2 diabetes mellitus	2.9e-05	0.000308	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—STAR—type 2 diabetes mellitus	2.9e-05	0.000308	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HSD17B3—type 2 diabetes mellitus	2.9e-05	0.000308	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	2.88e-05	0.000305	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	2.85e-05	0.000303	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	2.85e-05	0.000303	CbGpPWpGaD
Cyclizine—SULT1E1—Metabolism—AKT1—type 2 diabetes mellitus	2.85e-05	0.000302	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	2.81e-05	0.000298	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	2.78e-05	0.000295	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RBP4—type 2 diabetes mellitus	2.78e-05	0.000295	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CBS—type 2 diabetes mellitus	2.78e-05	0.000295	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ABCC8—type 2 diabetes mellitus	2.78e-05	0.000295	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AVP—type 2 diabetes mellitus	2.77e-05	0.000294	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	2.77e-05	0.000294	CbGpPWpGaD
Cyclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	2.77e-05	0.000294	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	2.76e-05	0.000293	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	2.74e-05	0.00029	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—COX2—type 2 diabetes mellitus	2.68e-05	0.000284	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC5A2—type 2 diabetes mellitus	2.68e-05	0.000284	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	2.64e-05	0.00028	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NCOA6—type 2 diabetes mellitus	2.63e-05	0.000279	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.63e-05	0.000279	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	2.6e-05	0.000275	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—UCP3—type 2 diabetes mellitus	2.58e-05	0.000274	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—UCP2—type 2 diabetes mellitus	2.58e-05	0.000274	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HSD11B1—type 2 diabetes mellitus	2.58e-05	0.000274	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—C3—type 2 diabetes mellitus	2.54e-05	0.000269	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	2.51e-05	0.000266	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.51e-05	0.000266	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	2.48e-05	0.000263	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IAPP—type 2 diabetes mellitus	2.46e-05	0.000261	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—INSR—type 2 diabetes mellitus	2.45e-05	0.00026	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PCK1—type 2 diabetes mellitus	2.43e-05	0.000258	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	2.41e-05	0.000256	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	2.41e-05	0.000255	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	2.4e-05	0.000255	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.39e-05	0.000254	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	2.39e-05	0.000254	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	2.36e-05	0.00025	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.33e-05	0.000247	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—C3—type 2 diabetes mellitus	2.31e-05	0.000244	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	2.29e-05	0.000243	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HK1—type 2 diabetes mellitus	2.28e-05	0.000241	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.27e-05	0.000241	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	2.23e-05	0.000236	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2.22e-05	0.000236	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	2.22e-05	0.000236	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	2.2e-05	0.000233	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GCKR—type 2 diabetes mellitus	2.2e-05	0.000233	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—KCNJ11—type 2 diabetes mellitus	2.2e-05	0.000233	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	2.2e-05	0.000233	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AGT—type 2 diabetes mellitus	2.19e-05	0.000232	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.16e-05	0.000229	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	2.15e-05	0.000228	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.15e-05	0.000228	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.12e-05	0.000224	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.11e-05	0.000224	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.11e-05	0.000223	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.11e-05	0.000223	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	2.11e-05	0.000223	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.08e-05	0.000221	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	2.05e-05	0.000217	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.02e-05	0.000215	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	2.01e-05	0.000213	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.98e-05	0.00021	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.96e-05	0.000208	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	1.96e-05	0.000208	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.95e-05	0.000207	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.93e-05	0.000204	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.93e-05	0.000204	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.9e-05	0.000201	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.89e-05	0.0002	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	1.83e-05	0.000194	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.8e-05	0.000191	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	1.79e-05	0.00019	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	1.79e-05	0.00019	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.77e-05	0.000188	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.77e-05	0.000188	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	1.76e-05	0.000186	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.75e-05	0.000185	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	1.75e-05	0.000185	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	1.75e-05	0.000185	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	1.75e-05	0.000185	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	1.74e-05	0.000184	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	1.7e-05	0.000181	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	1.68e-05	0.000179	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.68e-05	0.000178	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.66e-05	0.000176	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.64e-05	0.000174	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.64e-05	0.000174	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.63e-05	0.000173	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.62e-05	0.000172	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.61e-05	0.000171	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.58e-05	0.000168	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.58e-05	0.000167	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.57e-05	0.000167	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	1.57e-05	0.000166	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	1.57e-05	0.000166	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	1.57e-05	0.000166	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.56e-05	0.000165	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	1.54e-05	0.000163	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	1.52e-05	0.000162	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.51e-05	0.00016	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.5e-05	0.000159	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.49e-05	0.000158	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.48e-05	0.000157	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.43e-05	0.000152	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.42e-05	0.00015	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.42e-05	0.00015	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.42e-05	0.00015	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.39e-05	0.000148	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.38e-05	0.000146	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.37e-05	0.000146	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	1.36e-05	0.000144	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	1.36e-05	0.000144	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.36e-05	0.000144	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.3e-05	0.000138	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.3e-05	0.000137	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.29e-05	0.000137	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.27e-05	0.000135	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.27e-05	0.000134	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.27e-05	0.000134	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.25e-05	0.000133	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.2e-05	0.000127	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	1.17e-05	0.000124	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.17e-05	0.000124	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	1.16e-05	0.000124	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	1.15e-05	0.000122	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.13e-05	0.00012	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	1.12e-05	0.000118	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	1.09e-05	0.000115	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	1.08e-05	0.000115	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.07e-05	0.000113	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.07e-05	0.000113	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.05e-05	0.000111	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.05e-05	0.000111	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.04e-05	0.000111	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.04e-05	0.000111	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.04e-05	0.00011	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.01e-05	0.000107	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1e-05	0.000106	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.95e-06	0.000105	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	9.59e-06	0.000102	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	9.5e-06	0.000101	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	9.5e-06	0.000101	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	9.41e-06	9.98e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	9.12e-06	9.67e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	8.96e-06	9.5e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	8.94e-06	9.48e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	8.93e-06	9.47e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	8.83e-06	9.36e-05	CbGpPWpGaD
Cyclizine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	8.14e-06	8.63e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.06e-06	8.55e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.01e-06	8.5e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	7.78e-06	8.25e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	7.63e-06	8.09e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.62e-06	8.08e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.54e-06	8e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	7.39e-06	7.84e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	7.03e-06	7.45e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	6.99e-06	7.42e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.84e-06	7.26e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	6.69e-06	7.09e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	6.69e-06	7.09e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.28e-06	6.66e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.16e-06	6.53e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	6.12e-06	6.49e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.73e-06	5.02e-05	CbGpPWpGaD
Cyclizine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.37e-06	4.63e-05	CbGpPWpGaD
Cyclizine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	3.08e-06	3.26e-05	CbGpPWpGaD
